150 related articles for article (PubMed ID: 9045949)
1. Allelic loss of chromosome 16q in endometrial cancer: correlation with poor prognosis of patients and less differentiated histology.
Kihana T; Yano N; Murao S; Iketani H; Hamada K; Yano J; Murao S; Iketani H; Hamada K; Yano J; Matsuura S
Jpn J Cancer Res; 1996 Nov; 87(11):1184-90. PubMed ID: 9045949
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
[TBL] [Abstract][Full Text] [Related]
3. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers.
Dorion-Bonnet F; Mautalen S; Hostein I; Longy M
Genes Chromosomes Cancer; 1995 Nov; 14(3):171-81. PubMed ID: 8589033
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.
Driouch K; Dorion-Bonnet F; Briffod M; Champéme MH; Longy M; Lidereau R
Genes Chromosomes Cancer; 1997 Jul; 19(3):185-91. PubMed ID: 9219000
[TBL] [Abstract][Full Text] [Related]
5. High frequency of allelic imbalance at chromosome region 16q22-23 in human breast cancer: correlation with high PgR and low S phase.
Skirnisdottir S; Eiriksdottir G; Baldursson T; Barkardottir RB; Egilsson V; Ingvarrson S
Int J Cancer; 1995 Apr; 64(2):112-6. PubMed ID: 7615353
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
[TBL] [Abstract][Full Text] [Related]
7. Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.
Semczuk A; Marzec B; Skomra D; Roessner A; Cybulski M; Rechberger T; Schneider-Stock R
Oncology; 2005; 69(4):317-25. PubMed ID: 16293976
[TBL] [Abstract][Full Text] [Related]
8. Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients.
Kihana T; Hamada K; Inoue Y; Yano N; Iketani H; Murao S; Ukita M; Matsuura S
Cancer; 1995 Jul; 76(1):72-8. PubMed ID: 8630879
[TBL] [Abstract][Full Text] [Related]
9. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
Cleton-Jansen AM; van Eijk R; Lombaerts M; Schmidt MK; Van't Veer LJ; Philippo K; Zimmerman RM; Peterse JL; Smit VT; van Wezel T; Cornelisse CJ
BMC Cancer; 2008 Apr; 8():105. PubMed ID: 18416817
[TBL] [Abstract][Full Text] [Related]
10. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers.
Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J
Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204
[TBL] [Abstract][Full Text] [Related]
11. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
12. Pattern of chromosome 16q loss differs between an atypical proliferative lesion and an intraductal or invasive ductal carcinoma occurring subsequently in the same area of the breast.
Tsuda H; Takarabe T; Akashi-Tanaka S; Fukutomi T; Hirohashi S
Mod Pathol; 2001 May; 14(5):382-8. PubMed ID: 11353046
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity of chromosome 3p sequences is an infrequent event in endometrial cancer.
Arlt MF; Herzog TJ; Mutch DG; Goodfellow PJ
Gynecol Oncol; 1996 Feb; 60(2):308-12. PubMed ID: 8631557
[TBL] [Abstract][Full Text] [Related]
14. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
[TBL] [Abstract][Full Text] [Related]
15. Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
Mummert SK; Lobanenkov VA; Feinberg AP
Genes Chromosomes Cancer; 2005 Jun; 43(2):155-61. PubMed ID: 15761865
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
[TBL] [Abstract][Full Text] [Related]
18. Allelotype of endometrial carcinoma.
Fujino T; Risinger JI; Collins NK; Liu FS; Nishii H; Takahashi H; Westphal EM; Barrett JC; Sasaki H; Kohler MF
Cancer Res; 1994 Aug; 54(16):4294-8. PubMed ID: 8044774
[TBL] [Abstract][Full Text] [Related]
19. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer.
Cleton-Jansen AM; Moerland EW; Kuipers-Dijkshoorn NJ; Callen DF; Sutherland GR; Hansen B; Devilee P; Cornelisse CJ
Genes Chromosomes Cancer; 1994 Feb; 9(2):101-7. PubMed ID: 7513539
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]